Cargando…

Road to achieving COVID‐19 herd immunity in Niger Republic: Challenges and recommendations

COVID‐19 pandemic has had tremendous impact on countries across the world and Niger Republic is not left out of the ravaging impact of the virus. The rapid dissemination of the virus across the globe has led to the development of safe and efficacious vaccines at an unprecedented level. While Niger R...

Descripción completa

Detalles Bibliográficos
Autores principales: Abdou, Sil‐Ana Salissou, Amos, Oladunni Abimbola, Onwuemene, Ogechi Vida, Odey, Goodness Ogeyi, Nsikak Abasi, Caleb James
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9877972/
https://www.ncbi.nlm.nih.gov/pubmed/37519310
http://dx.doi.org/10.1002/puh2.38
_version_ 1784878426509803520
author Abdou, Sil‐Ana Salissou
Amos, Oladunni Abimbola
Onwuemene, Ogechi Vida
Odey, Goodness Ogeyi
Nsikak Abasi, Caleb James
author_facet Abdou, Sil‐Ana Salissou
Amos, Oladunni Abimbola
Onwuemene, Ogechi Vida
Odey, Goodness Ogeyi
Nsikak Abasi, Caleb James
author_sort Abdou, Sil‐Ana Salissou
collection PubMed
description COVID‐19 pandemic has had tremendous impact on countries across the world and Niger Republic is not left out of the ravaging impact of the virus. The rapid dissemination of the virus across the globe has led to the development of safe and efficacious vaccines at an unprecedented level. While Niger Republic has prioritized COVID‐19 vaccination in line with the global plan to attain herd immunity by vaccinating 70% of world's population, the country has continued to struggle to expand coverage of its population. Niger Republic is faced with challenges such as conflict, COVID‐19 vaccine hesitancy, poor COVID‐19 vaccine demand and inefficient information system, consequently leading to low COVID‐19 vaccine demand and uptake. These challenges coupled with the different wave of the pandemic, the latest largely driven by the Omicron variant has slowed down progress towards achieving herd immunity in Niger Republic. There is need for the Nigerien government to scale up vaccination drive as well as implement refined approaches towards achieving the country's herd immunity target. This paper aimed to discuss the current state of COVID‐19 vaccination including efforts and challenges towards achieving herd immunity in Niger Republic, thus informing strategies to ramp up COVID‐19 vaccination in the country.
format Online
Article
Text
id pubmed-9877972
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-98779722023-01-26 Road to achieving COVID‐19 herd immunity in Niger Republic: Challenges and recommendations Abdou, Sil‐Ana Salissou Amos, Oladunni Abimbola Onwuemene, Ogechi Vida Odey, Goodness Ogeyi Nsikak Abasi, Caleb James Public Health Challenges Commentary COVID‐19 pandemic has had tremendous impact on countries across the world and Niger Republic is not left out of the ravaging impact of the virus. The rapid dissemination of the virus across the globe has led to the development of safe and efficacious vaccines at an unprecedented level. While Niger Republic has prioritized COVID‐19 vaccination in line with the global plan to attain herd immunity by vaccinating 70% of world's population, the country has continued to struggle to expand coverage of its population. Niger Republic is faced with challenges such as conflict, COVID‐19 vaccine hesitancy, poor COVID‐19 vaccine demand and inefficient information system, consequently leading to low COVID‐19 vaccine demand and uptake. These challenges coupled with the different wave of the pandemic, the latest largely driven by the Omicron variant has slowed down progress towards achieving herd immunity in Niger Republic. There is need for the Nigerien government to scale up vaccination drive as well as implement refined approaches towards achieving the country's herd immunity target. This paper aimed to discuss the current state of COVID‐19 vaccination including efforts and challenges towards achieving herd immunity in Niger Republic, thus informing strategies to ramp up COVID‐19 vaccination in the country. John Wiley and Sons Inc. 2022-12-07 2022-12 /pmc/articles/PMC9877972/ /pubmed/37519310 http://dx.doi.org/10.1002/puh2.38 Text en © 2022 The Authors. Public Health Challenges published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed in accordance with the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) license, which permits others to distribute, remix, adapt and build upon this work, for commercial use, provided the original work is properly cited.
spellingShingle Commentary
Abdou, Sil‐Ana Salissou
Amos, Oladunni Abimbola
Onwuemene, Ogechi Vida
Odey, Goodness Ogeyi
Nsikak Abasi, Caleb James
Road to achieving COVID‐19 herd immunity in Niger Republic: Challenges and recommendations
title Road to achieving COVID‐19 herd immunity in Niger Republic: Challenges and recommendations
title_full Road to achieving COVID‐19 herd immunity in Niger Republic: Challenges and recommendations
title_fullStr Road to achieving COVID‐19 herd immunity in Niger Republic: Challenges and recommendations
title_full_unstemmed Road to achieving COVID‐19 herd immunity in Niger Republic: Challenges and recommendations
title_short Road to achieving COVID‐19 herd immunity in Niger Republic: Challenges and recommendations
title_sort road to achieving covid‐19 herd immunity in niger republic: challenges and recommendations
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9877972/
https://www.ncbi.nlm.nih.gov/pubmed/37519310
http://dx.doi.org/10.1002/puh2.38
work_keys_str_mv AT abdousilanasalissou roadtoachievingcovid19herdimmunityinnigerrepublicchallengesandrecommendations
AT amosoladunniabimbola roadtoachievingcovid19herdimmunityinnigerrepublicchallengesandrecommendations
AT onwuemeneogechivida roadtoachievingcovid19herdimmunityinnigerrepublicchallengesandrecommendations
AT odeygoodnessogeyi roadtoachievingcovid19herdimmunityinnigerrepublicchallengesandrecommendations
AT nsikakabasicalebjames roadtoachievingcovid19herdimmunityinnigerrepublicchallengesandrecommendations